{"text": "Becton Dickinson and Co on Tuesday forecast first-quarter revenue above Wall Street estimates due to strong demand for its COVID-19 diagnostic tests.The company said it expects quarterly revenue of $5.3 billion, above market expectation of $4.69 billion, according to Refinitiv IBES.The medical devices maker expects COVID-19 testing revenue of about $865 million for the first quarter."}